Influential Leaders- Focusing on Rick Shinto, Current Chief Executive Officer of InnovaCare Health Solutions

  1. Rick Shinto M.D has had quite an exciting career path. He has worked in many companies mostly in leadership positions. Currently, he serves as the CEOat InnovaCare Health Solutions and was working at Aveta Inc as the CEO before joining InnovaCare. At one point, he was the CEO at Medicare Mucho Mas also known as MMM and PMC Medicare Company. Dr. Rick has also worked as the CMO and Chief Operations Officer at Medical Pathways Management Company and as the Corporate VP of MedPartners.

 

He worked at MPMC for some time and later left to work as the CMO at Cal Optima in California, Orange County. Having over two decades experience in both operational and clinical healthcare, specifically managed care, Mr. Rick ensures that the health care system is efficiently functioning and providing quality services. He started off his career in Southern California as an internist and a specialized pulmonologist. Also, he was a board member of many healthcare firms like America’s Health Insurance Plans, CAPG and the FSSB of Managed Care for the Department of California.

 

He is also an author of articles of various aspects concerning healthcare systems and clinical medicine. He is a holder of a bachelors’ degree got from the University of California at Irvine and later joined the State University of New York in Stony Brook to study for his masters’ degree in medicine. He furthered his education in Redlands University where he obtained his M.B.A. His educational background was thus the stepping stone to his success, and he has greatly excelled in being an influential leader.

 

Rick Shinto is also a great team player he has been working with Penelope Kokkinides in InnovaCare for quite some time now. As the Chief Executive Officer, he has seen to it that all operations in InnovaCare are focused on the interests of people. With the help of Penelope, who is the CAO of InnovaCare Inc, the company has worked with government programs to ensure that healthcare services are available to all people. Penelope has thus dedicated her career to improving the organizational structures and efficiency of healthcare systems.

 

As top healthcare providers in North America, InnovaCare has greatly excelled and delivers services through Provider Networks, Medical Advantage, and Medical Programs, thanks to the excellent leadership of Dr. Rick and Ms. Penelope.

 

Sussex Healthcare Continues To Excel As It Looks To The Future

Sussex Healthcare, a renowned rehabilitation and eldercare system based in the UK, has been providing adult-care services to the southern coast of England for over 25 years.

The company, started with just a single care-home, has expanded to more than 20 facilities. Sussex’s reach includes more traditional offerings such as plush residential homes, as well as innovative and modern adult day-care locations and gyms. The award-winning organization has won the triple-crown in hospitality awards for its services, including the prestigious Hospitality Assured accreditation.

Sussex Healthcare’s specialty is in the treatment and care of the elderly population, coping with dementia and Alzheimer’s disease. Services, however, are not limited to the elder population segments, with treatments offered at all stages of adulthood to sufferers of cognitive and neurological impairments. Whether the patient’s needs require around-the-clock care, or periodic treatment, Sussex Healthcare’s physicians and staff are trained and ready to meet any need. The philosophy of the long-standing organization goes well beyond a patient’s healthcare needs, providing a holistic focus that involves leisure activities, an active social calendar, and a comprehensive approach to total health involving physical activity and a trained staff of chefs and nutritionists.

Sussex Healthcare, striving to build on a reputation for excellence, recently brought in a new Chief Executive, Amanda Morgan-Taylor, to spearhead the organization’s growth and future. The new CEO, who joined the company this past February, actually began acquainting herself with the organization and its services prior to entering her official role with Sussex. Morgan-Taylor has devoted the entirety of her 30-year career to health and social care organizations. She earned her first placement, as a mental health nurse, in 1984, eventually working her way into a series of successful leadership positions. She has acted as a manager, a director of quality development, and a managing director, prior to becoming Sussex Healthcare’s newest CEO.

Amanda Morgan-Taylor’s professional journey has included work with both local authorities and private healthcare providers. It is that vital combination that may be her greatest strength; she has the experience and wherewithal to unite the, at times, disparate plans of local councils and independent care providers, who are, whether they are always cognizant of it, working towards similar goals. The union between the two is fundamental to the success of Sussex and its patients. First, though, Morgan-Taylor plans to continue orientating herself to her new organization, its facilities, and its staff, before beginning the critical work to build connections in the communities Sussex Healthcare serves.

Eric Lefkofsky Ushers Tempus to Unicorn Status

Chicago-based cancer data-analytics Startup, Tempus, reached the coveted “unicorn” status in March of this year after securing an additional $80 million in funding from both new and existing donors. Startups valued at over $1 billion achieve this status. Since the company’s launch in 2015, Tempus’ worth is estimated to be at an approximate $1.1 billion. This distinction is not held by many other Chicagoland startups. After this latest funding round, Tempus has raised a total of $210 million.

Led by entrepreneur and co-founder, Eric Lefkofsky, Tempus has previously cemented its current position as one of Chicago’s top ten health techs. The company’s focus is to utilize big data to streamline cancer treatment and create a repository of all patient data, both molecular and clinical. This allows other physicians to search the database and garner a better understanding of how individuals with comparable genetic profiles have responded to specific treatments.

Tempus collaborates with all sectors of the health care system, including medical professionals and drug companies. They have partnered with approximately 50 leading research hospitals, including Chicago’s Rush University, Northwestern and University of Chicago. Tempus has also joined forces with multiple National Cancer Institute-designated Comprehensive Cancer Centers. Oncologists at those institutions routinely refer their patients to Tempus to undergo genomic sequencing to better personalize care.

Lefkofsky has said, “Tempus was born out of frustration with a health care system that too often let powerful data and real-world evidence go to waste. Given the breadth and scale of our current data set, we’re in a unique position to help usher in an era of precision medicine to support patients battling disease.” According to a company spokesperson, Tempus is expected to “touch 25 to 30 percent of cancer patients this year,” and is also eyeing diseases beyond cancer.